Fred E. Bertrand

2.8k total citations · 1 hit paper
37 papers, 2.2k citations indexed

About

Fred E. Bertrand is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Fred E. Bertrand has authored 37 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Hematology. Recurrent topics in Fred E. Bertrand's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Hedgehog Signaling Pathway Studies (6 papers) and Developmental Biology and Gene Regulation (4 papers). Fred E. Bertrand is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Hedgehog Signaling Pathway Studies (6 papers) and Developmental Biology and Gene Regulation (4 papers). Fred E. Bertrand collaborates with scholars based in United States, Italy and Canada. Fred E. Bertrand's co-authors include James A. McCubrey, George Sigounas, Linda S. Steelman, Massimo Libra, Jarrett T. Whelan, Richard A. Franklin, Caroline Angus, Steven L. Abrams, Jeffrey L. Salisbury and John Tayu Lee and has published in prestigious journals such as Blood, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Fred E. Bertrand

36 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

2006 550 citations James A. McCubrey, Linda S. Steelman et al. Advances in Enzyme Regulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fred E. Bertrand United States	21	1.3k	560	365	228	217	37	2.2k
Manabu Kawada Japan	28	1.5k 1.2×	891 1.6×	409 1.1×	380 1.7×	100 0.5×	207	3.2k
Ofer Kaplan Israel	24	567 0.4×	577 1.0×	400 1.1×	262 1.1×	196 0.9×	72	2.1k
Vincent Lemaître United States	26	622 0.5×	259 0.5×	461 1.3×	181 0.8×	59 0.3×	51	1.9k
Sabrina M. Ronen United States	40	2.4k 1.8×	432 0.8×	1.6k 4.4×	188 0.8×	136 0.6×	99	5.0k
Alex Lyakhovich Russia	25	1.1k 0.8×	357 0.6×	388 1.1×	73 0.3×	133 0.6×	71	1.7k
Dipankar Ray United States	25	1000 0.8×	548 1.0×	197 0.5×	99 0.4×	63 0.3×	102	1.7k
Carolyn E. Mountford Australia	40	1.4k 1.1×	266 0.5×	422 1.2×	76 0.3×	170 0.8×	137	3.9k
Hong Lin United States	23	2.2k 1.6×	366 0.7×	260 0.7×	118 0.5×	127 0.6×	50	2.6k
Mohammed Noor Tantawy United States	24	980 0.7×	326 0.6×	465 1.3×	192 0.8×	32 0.1×	58	2.0k
Kristine Glunde United States	42	3.0k 2.3×	648 1.2×	1.7k 4.7×	185 0.8×	99 0.5×	114	5.7k

Countries citing papers authored by Fred E. Bertrand

Since Specialization

Citations

This map shows the geographic impact of Fred E. Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred E. Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred E. Bertrand more than expected).

Fields of papers citing papers by Fred E. Bertrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred E. Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred E. Bertrand. The network helps show where Fred E. Bertrand may publish in the future.

Co-authorship network of co-authors of Fred E. Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of Fred E. Bertrand. A scholar is included among the top collaborators of Fred E. Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred E. Bertrand. Fred E. Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertrand, Fred E., et al.. (2024). Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes. Advances in Biological Regulation. 91. 101013–101013. 2 indexed citations

Bertrand, Fred E., et al.. (2023). A potential requirement for Smad3 phosphorylation in Notch-mediated EMT in colon cancer. Advances in Biological Regulation. 88. 100957–100957. 6 indexed citations

Bril, Fernando, Uche Ezeh, Mina Amiri, et al.. (2023). Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 109(1). 10–24. 52 indexed citations

Bertrand, Fred E.. (2020). The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(9). 118738–118738. 20 indexed citations

Fitzgerald, Timothy L., et al.. (2015). Notch‐1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer. Journal of Cellular Biochemistry. 116(11). 2517–2527. 125 indexed citations

Bertrand, Fred E., et al.. (2014). NOTCH and PTEN in prostate cancer. Advances in Biological Regulation. 56. 51–65. 43 indexed citations

Bertrand, Fred E., et al.. (2012). Developmental pathways in colon cancer. Cell Cycle. 11(23). 4344–4351. 139 indexed citations

Whelan, Jarrett T., et al.. (2009). Notch‐1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression. Journal of Cellular Biochemistry. 107(5). 992–1001. 49 indexed citations

Xie, Changan, et al.. (2007). Chromosomal analysis and identification based on optical tweezers and Raman spectroscopy: reply. Optics Express. 15(10). 6000–6000. 1 indexed citations

10.

Whelan, Jarrett T., et al.. (2007). CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression. Cell Cycle. 6(1). 80–84. 71 indexed citations

11.

McCubrey, James A., Linda S. Steelman, Steven L. Abrams, et al.. (2006). Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Advances in Enzyme Regulation. 46(1). 249–279. 550 indexed citations breakdown →

12.

Shelton, John G., Linda S. Steelman, Steven L. Abrams, et al.. (2005). Conditional EGFR Promotes Cell Cycle Progression and Prevention of Apoptosis in the Absence of Autocrine Cytokines. Cell Cycle. 4(6). 822–830. 23 indexed citations

13.

Chappell, William H., et al.. (2005). Increased Protein Expression of the PTEN Tumor Suppressor in the Presence of Constitutively Active Notch-1. Cell Cycle. 4(10). 1389–1395. 41 indexed citations

14.

Green, Thomas D., et al.. (2005). Activated EGFR Promotes the Survival of B-Lineage Acute Leukemia in the Absence of Stromal Cells. Cell Cycle. 4(3). 483–487. 9 indexed citations

15.

Shelton, John G., Linda S. Steelman, Steven L. Abrams, et al.. (2005). Effects of Endogenous Epidermal Growth Factor Receptor Signaling on DNA Synthesis and ERK Activation in a Cytokine-Dependent Hematopoietic Cell Line. Cell Cycle. 4(6). 818–821. 9 indexed citations

16.

Steelman, Linda S., Fred E. Bertrand, & James A. McCubrey. (2004). The complexity of PTEN: mutation, marker and potential target for therapeutic intervention. Expert Opinion on Therapeutic Targets. 8(6). 537–550. 76 indexed citations

17.

Golub, Rachel, Denise A. Martin, Fred E. Bertrand, et al.. (2001). VH Gene Replacement in Thymocytes. The Journal of Immunology. 166(2). 855–860. 7 indexed citations

18.

Shiokawa, Satoshi, Frank Mortari, José Lima, et al.. (1999). IgM Heavy Chain Complementarity-Determining Region 3 Diversity Is Constrained by Genetic and Somatic Mechanisms Until Two Months After Birth. The Journal of Immunology. 162(10). 6060–6070. 91 indexed citations

19.

Bertrand, Fred E., Rachel Golub, & Gillian E. Wu. (1998). VH gene replacement occurs in the spleen and bone marrow of non-autoimmune quasi-monoclonal mice. European Journal of Immunology. 28(10). 3362–3370. 26 indexed citations

20.

Bertrand, Fred E.. (1980). Giant multipole resonances : proceedings of the Giant Multipole Resonance Topical Conference held at the American Museum of Science and Energy, Oak Ridge, Tennessee, October 15-17, 1979. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact